Cargando…
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
A dysbiosis in microbial diversity or functionality can promote disease development. Emerging preclinical and clinical evidence emphasizes the interplay between microbiota and both disease evolution and the treatment response of different cancers. One bacterium that has garnered much attention in a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255244/ https://www.ncbi.nlm.nih.gov/pubmed/35800370 http://dx.doi.org/10.20517/cdr.2021.144 |